Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01266915 · ClinicalTrials.gov registry record
Cutaneous Lupus Registry
A clinical trial of Lupus Erythematosus, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT01266915: Recruiting study of Lupus Erythematosus, sponsored by University of Texas Southwestern Medical Center.
NCT01266915 is a study of Lupus Erythematosus that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,000 participants, above the 28-participant average among 3 other Lupus Erythematosus trials with a reported enrollment target (3471% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01266915, a study of Lupus Erythematosus, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Approximately 1.4 million individuals in the United States have systemic lupus erythematosus, and about 85% of these individuals develop skin lesions at some point of their disease. Cutaneous lupus erythematosus represents the skin manifestations of systemic lupus erythematosus, and can appear in people with or without systemic lupus. It is a mentally, physically, and emotionally debilitating disease that affects both the quality of life and social well-being of those affected. The cause of cutaneous lupus is not completely understood, but likely includes multiple factors from our genes and the environment. Multiple genetic studies with small numbers of cutaneous lupus patients have been performed to determine which genes are associated with cutaneous lupus. This study aims to accumulate even larger numbers of patients to confidently identify genes and the proteins they encode that could contribute greatly to the formation of cutaneous lupus. The discovery of these genes and proteins would help not only uncover how cutaneous lupus forms, but also improve our abilities to diagnose this disease and predict its course, and stimulate new drug development.
Conditions Studied
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2009-01 |
| Est. Completion | 2030-12 |
What NCT01266915 shows while recruiting
NCT01266915 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 28-participant average among 3 other Lupus Erythematosus trials with a reported enrollment target (3471% higher).
The record links to 1 condition, with Lupus Erythematosus appearing as the primary indexed condition, and to 0 interventions.
NCT01266915 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01266915 about?
NCT01266915 is a clinical study titled "Cutaneous Lupus Registry". Approximately 1.4 million individuals in the United States have systemic lupus erythematosus, and about 85% of these individuals develop skin lesions at some point of their disease. Cutaneous lupus erythematosus represents the skin manifestations of systemic lupus erythematosus, and can appear in pe...
What is the current status of trial NCT01266915?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2009-01. Estimated completion is 2030-12.
What conditions does trial NCT01266915 study?
This clinical trial studies the following conditions: Lupus Erythematosus.
Who is sponsoring clinical trial NCT01266915?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01266915 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lupus Erythematosus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia